Former

Former CEOs of JetBlue, Maersk Drilling, and Public Service Enterprise Group (PSEG) join Avina Clean Hydrogen’s distinguished advisory board

Retrieved on: 
Wednesday, April 3, 2024
Hydrogen, Physics, Maersk Drilling, University, AP, BP, Advisory board, U.S. Steel, Electronic, Steel, Independent, Copenhagen Business School, Bachelor of Science, Aviation, Columbia University, Public Service Enterprise Group, Risk intelligence, Robin, MBA, Doctor of Philosophy, JetBlue, CSR, Former, Electrical engineering, Maersk, Engineering, Management

SHORT HILLS, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Avina Clean Hydrogen is excited to announce the appointment of three renowned industry leaders to its Advisory Board.

Key Points: 
  • SHORT HILLS, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Avina Clean Hydrogen is excited to announce the appointment of three renowned industry leaders to its Advisory Board.
  • Ltd., and Ralph Izzo, Former Chairman and CEO of Public Service Enterprise Group (PSEG), join the existing distinguished panel of advisory board members, bringing valuable expertise and insight to the company's projects in the clean fuels sector.
  • "We are thrilled to welcome our new Advisory Board members," said Vishal Shah, Founder & CEO of Avina Clean Hydrogen.
  • Their expertise will complement our existing prestigious Advisory Board members, enabling us to collaborate effectively in building a world-class company that delivers compelling clean fuel solutions to the market,” said Steven Berkenfeld, Board Member of Avina.

Update - LiveOne (NASDAQ: LVO) Hosts Event Celebrating Women in the Entertainment Industry

Retrieved on: 
Wednesday, March 27, 2024
LVO, Entertainment, Female, Woman, Black, LiveOne, Warner Bros., Former, Music, LOS, Industry average, UCLA

LiveOne Team is over 40% Female, Outperforming Industry Average of 30%

Key Points: 
  • LiveOne Team is over 40% Female, Outperforming Industry Average of 30%
    LiveOne has Streamed Over 1K Top Female Artists, including Taylor Swift, Adele and Olivia Rodrigo, to 100M+ Viewers
    Fans Can Watch on Friday, March 29th at 4:00pm PT at https://www.liveone.com/live-events/event/women-in-entertainment
    LOS ANGELES, CA, March 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – LiveOne (NASDAQ: LVO), an award-winning, creator-first, music, entertainment and technology platform, announced today that it will stream the latest edition of LiveOne Presents: Celebrating Women in the Entertainment Industry.
  • In recognition of Women’s History Month, the event will include a performance by artist and songwriter, Tabi, who currently has a Top 50 song on urban radio with Josh Levi’s “Birthday Dance.”
    The event will also include a riveting panel discussion with female executives across the entertainment industry including:
    Carolyn Blackwood - Former COO, Warner Bros.
    Tiffany Naiman - Director of Music Industry Program, UCLA
    Samantha Maners - Artist Manager, blackbear
    Paige Kaplan - Entertainment Attorney, Greenberg Traurig
    LiveOne CEO Robert Ellin commented, “We are committed to equality and to increasing leadership opportunities for our all employees.
  • Embracing the perspectives and talents of a diverse collaborative on our leadership team isn't just a matter of fairness; it's a strategic imperative which strengthens our decision-making, fosters innovation, and drives sustainable success.”
    The performance and panel discussion will be streamed and available on LiveOne.com beginning Friday, March 29th at 4:00pm PT.

LiveOne (NASDAQ: LVO) Hosts Event Celebrating Women in the Entertainment Industry

Retrieved on: 
Wednesday, March 27, 2024
LVO, Entertainment, Female, Woman, Black, LiveOne, Warner Bros., Former, Music, LOS, Industry average, UCLA

LiveOne Team is over 40% Female, Outperforming Industry Average of 30%

Key Points: 
  • LiveOne Team is over 40% Female, Outperforming Industry Average of 30%
    LiveOne has Streamed Over 1K Top Female Artists, including Taylor Swift, Adele and Olivia Rodrigo, to 100M+ Viewers
    Fans Can Watch on Saturday, March 30th at 5:00pm PT on LiveOne.com
    LOS ANGELES, CA, March 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- LiveOne (NASDAQ: LVO), an award-winning, creator-first, music, entertainment and technology platform, announced today that it will stream the latest edition of LiveOne Presents: Celebrating Women in the Entertainment Industry.
  • In recognition of Women’s History Month, the event will include a performance by artist and songwriter, Tabi, who currently has a Top 50 song on urban radio with Josh Levi’s “Birthday Dance.”
    The event will also include a riveting panel discussion with female executives across the entertainment industry including:
    Carolyn Blackwood - Former COO, Warner Bros.
    Tiffany Naiman - Director of Music Industry Program, UCLA
    Samantha Maners - Artist Manager, blackbear
    Paige Kaplan - Entertainment Attorney, Greenberg Traurig
    LiveOne CEO Robert Ellin commented, “We are committed to equality and to increasing leadership opportunities for our all employees.
  • Embracing the perspectives and talents of a diverse collaborative on our leadership team isn't just a matter of fairness; it's a strategic imperative which strengthens our decision-making, fosters innovation, and drives sustainable success.”
    The performance and panel discussion will be streamed and available on LiveOne.com beginning Saturday, March 30th at 5:00pm PT.

Nvelop Therapeutics Launches with Dual Platforms for In Vivo Delivery of the Next Generation of Genetic Medicines

Retrieved on: 
Tuesday, April 9, 2024
Research, Medical Supplies, Infectious Diseases, Genetics, Biotechnology, Other Health, Health, Pharmaceutical, Science, Culture, Broad Institute, Cell, Massachusetts General Hospital, Partner (business rank), Environment, Trust, RNP, MIT, Spark Therapeutics, Patient, Harvard University, Nature Biotechnology, Tissue, Head, Protein, Therapy, Former, Safety, Royal Naval Patrol Service, FDA, Management

Nvelop Therapeutics , a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of therapeutic cargo, today formally announced its launch to develop the next generation of genetic medicines for a wide range of diseases.

Key Points: 
  • Nvelop Therapeutics , a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of therapeutic cargo, today formally announced its launch to develop the next generation of genetic medicines for a wide range of diseases.
  • The company’s approach has the potential to enable highly efficient and cell-specific delivery of a broad set of therapeutic cargoes.
  • “The field of genetic medicine is significantly limited by the challenge of efficiently delivering therapeutic cargoes to many types of target cells in vivo,” said Jeff Walsh, Nvelop’s Chief Executive Officer.
  • In vivo data for the second platform is expected to be disclosed at one or more scientific meetings this year.

Valeos Welcomes Dr. Stuart Sweet to Board of Directors

Retrieved on: 
Tuesday, April 9, 2024
American Express, Advisory Committee, Transplant, Organ transplantation, St. Louis Children's Hospital, GM, Information technology, Medicine, Entrepreneurship, CPO, Patient, SVP, CISO, Research, Organ, Human services, Doctor of Philosophy, Lung transplantation, MD, Quality of life, Health policy, Former, Hospital, Author, Ecosystem, OPTN, Government, Pediatrics, Dentistry

WASHINGTON, April 9, 2024 /PRNewswire/ -- Valeos, a 501(c)(3) nonprofit organization designed to improve organ transplant outcomes for patients and organ donors through data collaboration, today announced the appointment of Dr. Stuart C. Sweet, MD, PhD to its Board of Directors. Dr. Sweet is the W. McKim Marriott Professor of Pediatrics at Washington University in St. Louis, MO, and served as the 2016-2017 Board President of the Organ Procurement and Transplantation Network (OPTN), the U.S. national transplant system. Dr. Sweet spent more than two decades as the medical director of the pediatric lung transplant program at Washington University School of Medicine in St. Louis and St. Louis Children's Hospital, focusing clinically on pediatric lung transplantation and gaining expertise in organ allocation, clinical outcomes, health policy and the role of information technology in medicine.

Key Points: 
  • "I am honored to join the exceptional team at Valeos and continue my dedication to advancing the U.S. organ transplant system," said Dr. Sweet.
  • "We're excited to welcome Dr. Sweet to our Board of Directors.
  • This announcement follows an exciting year for Valeos, which saw its first appointments to its Board of Directors and Advisory Committee this past January.
  • With the backing of leading figures in healthcare, technology and government, Valeos is committed to building the world's largest de-identified transplant data sandbox.

NEO Battery Materials Announces Change of Auditor to MNP LLP

Retrieved on: 
Wednesday, March 20, 2024
NEO, MNP, Successor, National instrument, OTC, Former, Change, MNP LLP, Silicon, Audit

TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce that it has changed its auditors from DeVisser Gray LLP (“Former Auditor”) to MNP LLP (“Successor Auditor”), effective March 19, 2024.

Key Points: 
  • TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce that it has changed its auditors from DeVisser Gray LLP (“Former Auditor”) to MNP LLP (“Successor Auditor”), effective March 19, 2024.
  • NEO Battery’s board of directors accepted the resignation of DeVisser Gray LLP and appointed MNP LLP as the new auditor of the Company, effective March 19, 2024, until the Company’s next annual general meeting of shareholders.
  • There were no reservations in the Former Auditor’s audit reports for any financial period during which the Former Auditor was the Company’s auditor.
  • There are no “reportable events” (as the term is defined in National Instrument 51-102 – Continuous Disclosure Obligations) between the Company and the Former Auditor.

Anson Funds Comments on Recent Events at Twilio

Retrieved on: 
Thursday, April 4, 2024
Professional Services, Finance, Pressure, Former

Anson Funds Management LP and Anson Advisors Inc., the co-investment advisers of certain investment funds (collectively, “Anson Funds”), and significant stockholders of Twilio Inc. (NYSE: TWLO) (“Twilio” or the “Company”), today commented on recent actions taken by Twilio’s Board of Directors (the “Board”).

Key Points: 
  • Anson Funds Management LP and Anson Advisors Inc., the co-investment advisers of certain investment funds (collectively, “Anson Funds”), and significant stockholders of Twilio Inc. (NYSE: TWLO) (“Twilio” or the “Company”), today commented on recent actions taken by Twilio’s Board of Directors (the “Board”).
  • Sagar Gupta, Portfolio Manager and Head of Active Engagement at Anson Funds, stated:
    “Following discussions between Anson Funds and the Company’s representatives that were ongoing through yesterday evening, Twilio’s Board issued a press release last night announcing the departure of long-tenured director Byron Deeter and a proposal to declassify the Board.
  • During Anson Funds’ engagement with Twilio, the Company repeatedly rejected our proposals for governance improvements, the departure of directors with significant conflicts of interest and little relevance, and stockholder representation on the Board.
  • Only under intense pressure from Anson Funds have Twilio’s directors taken steps to address these issues, highlighting the exceptional level of dysfunction within Twilio’s boardroom.

Guild Appoints Bijal Shah CEO

Retrieved on: 
Tuesday, April 2, 2024
Professional Services, Education, Technology, Human Resources, Software, Training, American Express, Growth, Stroke, Former, Workforce, Interim, Family, Engineering, Management

Guild , the leader in opportunity creation for America’s workforce, today announced that the company’s Board of Directors unanimously appointed Bijal Shah CEO and is adding her to the Board of Directors.

Key Points: 
  • Guild , the leader in opportunity creation for America’s workforce, today announced that the company’s Board of Directors unanimously appointed Bijal Shah CEO and is adding her to the Board of Directors.
  • Joining Guild in 2018 as the company’s first Chief Product Officer, Bijal led a wide variety of teams, including product, engineering, and analytics.
  • In August 2023, Shah was appointed Interim CEO when Guild’s Founder and Former CEO, Rachel Romer, suffered a stroke.
  • I’m thrilled to support Bijal, and I have no doubt that Guild will thrive under her leadership.”

PharmaJet Announces Scientific Advisory Boards and Presentation at World Vaccine Congress in Washington on April 1

Retrieved on: 
Monday, April 1, 2024
Oncology, Health, Medical Devices, Infectious Diseases, Health Technology, Pharmaceutical, Biotechnology, MSD, Research, Clinical research, Government, Congress, Global health, Policy, Cancer, University, Infection, Former, Injection, Emerita, SAB, Immune system, Therapy, Use, Multimedia, Vaccine, Chiron, Medical director

The Boards will provide strategic guidance and expertise to help PharmaJet advance its vision to better activate the immune system with its unique technology and accelerate its partnering strategy with vaccine and pharmaceutical companies.

Key Points: 
  • The Boards will provide strategic guidance and expertise to help PharmaJet advance its vision to better activate the immune system with its unique technology and accelerate its partnering strategy with vaccine and pharmaceutical companies.
  • View the full release here: https://www.businesswire.com/news/home/20240401778401/en/
    In the countries highlighted, PharmaJet has commercial and development partners for prophylactic vaccines for the prevention of infectious diseases as well as cancer treatments.
  • To date, more than 10 million vaccinations have been made and PharmaJet has over 80 global development partners.
  • To find out how this innovative technology can help your vaccine or therapeutic program, schedule a meeting with one of our company experts by clicking here .

MyPrize Emerges Out of Stealth With $140 Million Total Enterprise Value, the Most Valuable Online Social Casino Pre-Launch

Retrieved on: 
Wednesday, March 27, 2024
Professional Services, Entertainment, Technology, Cryptocurrency, Internet, Casino, Gaming, CIO, Dragonfly, Friends, Entrepreneurship, FTX, General partnership, Kadoorie family, Galaxy Digital, Silicon, Jack Entertainment, XP, Justice, Former, Bruch, Multimedia, Blockchain.com

MyPrize transcends those boundaries, giving players and fans what they have been desperately craving: a unified, open platform that combines the best of both online gaming and streaming.

Key Points: 
  • MyPrize transcends those boundaries, giving players and fans what they have been desperately craving: a unified, open platform that combines the best of both online gaming and streaming.
  • MyPrize radically transforms the way players can interact and engage with their favorite streamers, friends, and online games together.
  • MyPrize brings scale and institutional credibility to this emerging industry as the most valuable venture-backed online social casino pre-launch.
  • "With the support of our investors and our team’s commitment to rapid product innovation, MyPrize will define the future of online social gaming."